Summit Therapeutics' leading candidate is showing promise in a key oncology market. Three years ago, Summit Therapeutics ...

Sarepta Therapeutics has rejected a call by the Food and Drug Administration to stop shipments of its muscular dystrophy drug.

On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...

Shares of Viking Therapeutics soared last year on high hopes for its obesity drug VK2735. The stock stumbled beginning in ...

Mounjaro suppresses the appetite of the user, as well as increases their sense of fullness, by activating two receptors ...

Shares of drug developer Sarepta Therapeutics surged more than 20% in morning trading, rising after the late-Wednesday news that the company would shrink its workforce and pause several developmental ...

Anthem Biosciences Ltd's shares debuted with a 27% premium over the issue price, initially trading at Rs 723.10 on the BSE.

UCSF researchers find that two FDA-approved cancer drugs significantly improve memory in Alzheimer’s mouse models and reduce ...

Johnson & Johnson reported second-quarter results on July 16. Sales of pharmaceuticals have been muted due to a loss of ...

GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...

Mirum Pharmaceuticals MIRM has delivered a stellar performance over the past three months. Shares of the company have rallied ...